{"id":"https://openalex.org/W112355453","doi":null,"title":"Influence of cholesterol-lowering on plasma membrane lipids and function.","display_name":"Influence of cholesterol-lowering on plasma membrane lipids and function.","publication_year":1996,"publication_date":"1996-03-01","ids":{"openalex":"https://openalex.org/W112355453","mag":"112355453","pmid":"https://pubmed.ncbi.nlm.nih.gov/8740244"},"language":"en","primary_location":{"id":"pmid:8740244","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/8740244","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Methods and findings in experimental and clinical pharmacology","raw_type":"Clinical Trial"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5109139734","display_name":"P. Lijnen","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I99464096","display_name":"KU Leuven","ror":"https://ror.org/05f950310","country_code":"BE","type":"education","lineage":["https://openalex.org/I99464096"]}],"countries":["BE"],"is_corresponding":false,"raw_author_name":"P Lijnen","raw_affiliation_strings":["Department of Molecular and Cardiovascular Research, University of Leuven (KULeuven), Belgium"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Molecular and Cardiovascular Research, University of Leuven (KULeuven), Belgium","institution_ids":["https://openalex.org/I99464096"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5026305740","display_name":"D Echevar\u00eda-V\u00e1zquez","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"D Echevar\u00eda-V\u00e1zquez","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":null,"display_name":"V Petrov","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"V Petrov","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.2924,"has_fulltext":false,"cited_by_count":43,"citation_normalized_percentile":{"value":0.57386692,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":97},"biblio":{"volume":"18","issue":"2","first_page":"123","last_page":"36"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10394","display_name":"Lipoproteins and Cardiovascular Health","score":0.6460000276565552,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10394","display_name":"Lipoproteins and Cardiovascular Health","score":0.6460000276565552,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11618","display_name":"Cholesterol and Lipid Metabolism","score":0.22010000050067902,"subfield":{"id":"https://openalex.org/subfields/1303","display_name":"Biochemistry"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10407","display_name":"Lipid Membrane Structure and Behavior","score":0.12049999833106995,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/pravastatin","display_name":"pravastatin","score":0.9520000219345093},{"id":"https://openalex.org/keywords/statins","display_name":"statins","score":0.9660000205039978},{"id":"https://openalex.org/keywords/hypercholesterolemia","display_name":"hypercholesterolemia","score":0.8920000195503235},{"id":"https://openalex.org/keywords/plasma-membrane-cholesterol","display_name":"plasma membrane cholesterol","score":0.7170000076293945},{"id":"https://openalex.org/keywords/erythrocyte-membrane","display_name":"erythrocyte membrane","score":0.7979999780654907},{"id":"https://openalex.org/keywords/platelet-membrane","display_name":"platelet membrane","score":0.9850000143051147},{"id":"https://openalex.org/keywords/na-k-atpase","display_name":"Na+/K+-ATPase","score":0.8700000047683716},{"id":"https://openalex.org/keywords/intracellular-sodium","display_name":"intracellular sodium","score":0.5170000195503235},{"id":"https://openalex.org/keywords/intracellular-potassium","display_name":"intracellular potassium","score":0.8999999761581421},{"id":"https://openalex.org/keywords/intracellular-magnesium","display_name":"intracellular magnesium","score":0.6769999861717224},{"id":"https://openalex.org/keywords/intracellular-calcium","display_name":"intracellular calcium","score":0.9259999990463257},{"id":"https://openalex.org/keywords/apolipoprotein-b","display_name":"apolipoprotein B","score":0.7300000190734863},{"id":"https://openalex.org/keywords/apolipoprotein-a-i","display_name":"apolipoprotein A-I","score":0.7940000295639038},{"id":"https://openalex.org/keywords/apolipoprotein-a-ii","display_name":"apolipoprotein A-II","score":0.9879999756813049},{"id":"https://openalex.org/keywords/lipoprotein-a","display_name":"lipoprotein(a)","score":0.734000027179718},{"id":"https://openalex.org/keywords/lcat","display_name":"lecithin:cholesterol acyltransferase","score":0.9700000286102295}],"concepts":[{"id":"https://openalex.org/C2779519902","wikidata":"https://www.wikidata.org/wiki/Q1240093","display_name":"Pravastatin","level":3,"score":0.9721029996871948},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.7321186661720276},{"id":"https://openalex.org/C62746215","wikidata":"https://www.wikidata.org/wiki/Q14890615","display_name":"Apolipoprotein B","level":3,"score":0.729853630065918},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.7255092263221741},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.6459242701530457},{"id":"https://openalex.org/C2778163477","wikidata":"https://www.wikidata.org/wiki/Q43656","display_name":"Cholesterol","level":2,"score":0.6197441220283508},{"id":"https://openalex.org/C2777320049","wikidata":"https://www.wikidata.org/wiki/Q2989497","display_name":"Hydroxymethylglutaryl-CoA reductase","level":5,"score":0.6140238642692566},{"id":"https://openalex.org/C8243546","wikidata":"https://www.wikidata.org/wiki/Q419074","display_name":"Very low-density lipoprotein","level":4,"score":0.518354058265686},{"id":"https://openalex.org/C2780072125","wikidata":"https://www.wikidata.org/wiki/Q28350","display_name":"Lipoprotein","level":3,"score":0.5048044919967651},{"id":"https://openalex.org/C27081682","wikidata":"https://www.wikidata.org/wiki/Q269829","display_name":"Placebo","level":3,"score":0.49254998564720154},{"id":"https://openalex.org/C139572402","wikidata":"https://www.wikidata.org/wiki/Q4927820","display_name":"Blood lipids","level":3,"score":0.4917486011981964},{"id":"https://openalex.org/C19720800","wikidata":"https://www.wikidata.org/wiki/Q7722","display_name":"Morning","level":2,"score":0.4216564893722534},{"id":"https://openalex.org/C104950815","wikidata":"https://www.wikidata.org/wiki/Q415607","display_name":"HMG-CoA reductase","level":4,"score":0.353367418050766},{"id":"https://openalex.org/C134651460","wikidata":"https://www.wikidata.org/wiki/Q3100717","display_name":"Reductase","level":3,"score":0.22531390190124512},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.20343804359436035},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.17678993940353394},{"id":"https://openalex.org/C181199279","wikidata":"https://www.wikidata.org/wiki/Q8047","display_name":"Enzyme","level":2,"score":0.05792415142059326},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.0},{"id":"https://openalex.org/C204787440","wikidata":"https://www.wikidata.org/wiki/Q188504","display_name":"Alternative medicine","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000214","descriptor_name":"Acyl Coenzyme A","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":false},{"descriptor_ui":"D000254","descriptor_name":"Sodium-Potassium-Exchanging ATPase","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D000254","descriptor_name":"Sodium-Potassium-Exchanging ATPase","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000924","descriptor_name":"Anticholesteremic Agents","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D000924","descriptor_name":"Anticholesteremic Agents","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D000924","descriptor_name":"Anticholesteremic Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D001053","descriptor_name":"Apolipoproteins","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D001792","descriptor_name":"Blood Platelets","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D001792","descriptor_name":"Blood Platelets","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D002462","descriptor_name":"Cell Membrane","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D002462","descriptor_name":"Cell Membrane","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D002784","descriptor_name":"Cholesterol","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":true},{"descriptor_ui":"D004311","descriptor_name":"Double-Blind Method","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004791","descriptor_name":"Enzyme Inhibitors","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D004791","descriptor_name":"Enzyme Inhibitors","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D004791","descriptor_name":"Enzyme Inhibitors","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D004912","descriptor_name":"Erythrocytes","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D004912","descriptor_name":"Erythrocytes","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006937","descriptor_name":"Hypercholesterolemia","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D006937","descriptor_name":"Hypercholesterolemia","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D007862","descriptor_name":"Phosphatidylcholine-Sterol O-Acyltransferase","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008563","descriptor_name":"Membrane Lipids","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":true},{"descriptor_ui":"D010743","descriptor_name":"Phospholipids","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":true},{"descriptor_ui":"D014280","descriptor_name":"Triglycerides","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D017035","descriptor_name":"Pravastatin","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D017035","descriptor_name":"Pravastatin","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D017035","descriptor_name":"Pravastatin","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false}],"locations_count":2,"locations":[{"id":"pmid:8740244","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/8740244","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Methods and findings in experimental and clinical pharmacology","raw_type":"Clinical Trial"},{"id":"mag:112355453","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/8740244","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"PubMed","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.9922999739646912}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2045223821","https://openalex.org/W4294549519","https://openalex.org/W2006766721","https://openalex.org/W2432214708","https://openalex.org/W2404692256","https://openalex.org/W2134627002","https://openalex.org/W80090535","https://openalex.org/W2039924767","https://openalex.org/W2010888042","https://openalex.org/W1965291261"],"abstract_inverted_index":{"In":[0],"order":[1],"to":[2,145,256,393],"determine":[3],"whether":[4],"alterations":[5],"in":[6,16,34,99,105,177,189,195,269,336,341,345,354,363,371,378,389],"membrane":[7,25,115,264,349,356,379],"or":[8,63,73,182,185],"plasma":[9,27,117,150,163,178,197,217,248,355],"lipids":[10,118,380],"affect":[11],"transmembrane":[12],"cationic":[13,20,121],"transport":[14],"systems":[15],"erythrocytes":[17],"and":[18,22,30,38,87,116,119,123,133,138,155,159,162,165,202,220,227,230,262,275,287,297,304,314,318,321,347,368,381],"platelets,":[19],"fluxes":[21,122],"intracellular":[23,372],"concentrations,":[24,124],"lipids,":[26,28],"lipoproteins":[29],"apolipoproteins":[31],"were":[32,54,167,187,324],"measured":[33],"hypercholesterolemic":[35,337],"patients":[36,53,338],"before":[37],"during":[39,77,83,90,169,213,243,281,327,384],"administration":[40],"of":[41,114,120,128,141,152,172,199,203,208],"a":[42,47,342,369],"HMG-CoA":[43],"reductase":[44],"inhibitor.":[45],"After":[46],"1-month":[48],"placebo":[49,59,130,147,258],"run-in":[50,131],"period,":[51],"the":[52,78,84,91,100,106,126,129,146,149,190,196,216,247,257,260,270,285,295,310,319,364],"treated":[55],"double-blind":[56],"either":[57],"with":[58,64],"(n":[60,66],"=":[61,67],"25)":[62,68],"pravastatin":[65,74,142,173,214,244,282,328],"for":[69,112],"6":[70,139,170],"months.":[71],"Placebo":[72],"10":[75],"mg":[76,82,89],"1st":[79],"month,":[80],"20":[81],"2nd":[85],"month":[86],"40":[88],"additional":[92],"4":[93],"months":[94,140,171],"was":[95,103,211,267,279,292],"administered":[96],"once":[97],"daily":[98],"evening.":[101],"Blood":[102],"collected":[104],"morning":[107],"after":[108,134],"an":[109,361],"overnight":[110],"fast":[111],"assay":[113],"at":[125],"end":[127],"period":[132],"1,":[135],"2,":[136],"3":[137],"therapy.":[143,174],"Compared":[144,255],"group":[148,259],"concentration":[151,278,303],"total":[153],"cholesterol":[154,158,160,250,265,334,350,357,385],"phospholipids,":[156],"free":[157],"esters,":[161],"LDL-cholesterol":[164],"LDL-phospholipids":[166],"decreased":[168],"No":[175],"changes":[176,353,377],"VLDL-,":[179],"HDL-,":[180],"HDL2-":[181,226],"HDL3-cholesterol,":[183],"phospholipids":[184],"triglycerides":[186],"observed":[188,212,383],"pravastatin-treated":[191,271],"patients.":[192,272],"A":[193],"decrease":[194,344,370],"level":[198],"apolipoprotein":[200,218],"B":[201],"LDL-apo":[204],"B,":[205,210],"but":[206],"not":[207,241,325],"VLDL-apo":[209],"therapy;":[215],"AI":[219,229],"AII":[221,232],"levels,":[222,233],"as":[223,225,307,309],"well":[224,308],"HDL3-apo":[228],"apo":[231],"however,":[234],"remained":[235],"unchanged.":[236],"Plasma":[237],"lipoprotein":[238],"Lp(a)":[239],"did":[240],"change":[242],"therapy,":[245],"while":[246,284],"lecithin":[249],"acyltransferase":[251],"activity":[252,291,317,367],"(LCAT)":[253],"increased.":[254,293],"erythrocyte":[261,286,311,346],"platelet":[263,288,348],"content":[266,306],"reduced":[268,280],"The":[273],"intraerythrocyte":[274,296],"intraplatelet":[276,298],"Na+":[277,320,365,373],"administration,":[283],"Na+/K+":[289,315],"pump":[290,366],"However,":[294],"K+,":[299],"Mg2+,":[300],"cytosolic":[301],"Ca2+":[302],"water":[305],"Na+/Li+":[312],"countertransport":[313],"cotransport":[316],"K+":[322],"leak":[323],"changed":[326],"treatment.":[329],"Our":[330],"data":[331],"show":[332],"that":[333],"lowering":[335,386],"may":[339],"result":[340],"significant":[343],"content.":[351],"These":[352],"are":[358],"accompanied":[359],"by":[360],"increase":[362],"concentration.":[374],"Whether":[375],"these":[376],"function":[382],"also":[387],"occur":[388],"other":[390],"cells":[391],"remains":[392],"be":[394],"further":[395],"elucidated.":[396]},"counts_by_year":[{"year":2021,"cited_by_count":2},{"year":2019,"cited_by_count":1},{"year":2018,"cited_by_count":1},{"year":2017,"cited_by_count":1},{"year":2016,"cited_by_count":1},{"year":2015,"cited_by_count":1},{"year":2013,"cited_by_count":3},{"year":2012,"cited_by_count":2}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}